NutraLife BioSciences, Inc.

NLBS

US67098B1070

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 01:45:42 2024-03-01 pm EST			5-day change	1st Jan Change
0.0001 ^USD	-66.67%		-.--%	-50.00%

2023	NutraLife BioSciences, Inc. (OTCPK : NLBS) entered into a Stock Exchange Agreement to acquire Healthcare Concierges USA, Inc. from Mrugesh Patel, Pinal Kerai and Aysha Khan for 2 million.	CI
2022	NutraLife BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI

NutraLife BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022

August 22, 2022 at 12:11 pm EDT

NutraLife BioSciences, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.055835 million compared to USD 0.039096 million a year ago. Net loss was USD 0.900438 million compared to USD 1.81 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
For the six months, sales was USD 0.136313 million compared to USD 0.175469 million a year ago. Net loss was USD 1.98 million compared to USD 4.31 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago.

Latest news about NutraLife BioSciences, Inc.

NutraLife BioSciences, Inc. (OTCPK : NLBS) entered into a Stock Exchange Agreement to acquire Healthcare Concierges USA, Inc. from Mrugesh Patel, Pinal Kerai and Aysha Khan for 2 million.	23-02-27	CI
NutraLife BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
NutraLife Biosciences, Inc. Executes Master Distribution Agreement with Whole Foods Full Spectrum Processing	22-10-27	CI
NutraLife BioSciences, Inc. announced that it has received $0.04 million in funding	22-09-11	CI
NutraLife BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-22	CI
Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro	22-07-08	CI
NutraLife BioSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
NutraLife BioSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-11	CI
NutraLife BioSciences, Inc. Auditor Raises 'Going Concern' Doubt	22-04-10	CI
Nutralife Biosciences Signs Partnership Agreement with Cookies Licensed Retail Products	22-02-01	CI
NutraLife BioSciences, Inc. Partners with KOR Medical to Create Cannabinoid-Based Wellness Products	21-12-17	CI
NutraLife BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Nutralife Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-07-16	CI
Nutralife Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-06-24	CI
Nutralife Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	21-04-12	CI
NutraLife BioSciences, Inc. Receives Reorder and Begins Production of The Oral Sanitizer Mouth Spray For Indonesian Distributor Kinerjapay Corp	21-02-11	CI
NutraLife BioSciences, Inc. Finalizes Product Registration With The U.S. FDA	20-12-18	CI
NutraLife BioSciences, Inc. Signs Multi-Year Manufacturing, Distribution and Sales Agreement with 27Health Inc. for the Launch of Covi-Guard™ Oral Sanitizer	20-11-05	CI
NutraLife BioSciences, Inc. announced a financing transaction	20-08-13	CI
NutraLife Biosciences, Inc. Begins Manufacturing Sanitizers Amid the COVID-19 Global Pandemic	20-03-30	CI
NutraLife Biosciences, Inc. Announces Launch of New Product Line Phytocannabinoid-Rich Skincare	19-12-05	CI
Omni Medical Services and NutraLife Biosciences Inc. Announce NutraLife to Manufacture and Provide Finished CBD Products for Omni’s New Line of Omni CBD Solutions	19-12-03	CI
Nutralife Biosciences, Inc. Announces Earnings Results for the Quarter and Six Months Ended June 30Th, 2019	19-08-22	CI
NutraLife BioSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-17	CI
Nutralife Biosciences, Inc. Launches a New Line of Phytocannabinoid Rich Water Enhancing Drops Under Its New In-House Brand PCR Pure	19-04-16	CI

Chart NutraLife BioSciences, Inc.

Duration

Period

More charts

Company Profile

NutraLife BioSciences, Inc. is engaged in the development and distribution of nutritional and dietary oral spray products. The Company is a producer and distributor of nutritional supplements that uses micro molecular formulae and the utilization of an oral spray to provide efficient absorption. Its products are sold to private label distributors who sell the products it manufactures under their own brand name. The Company manufactures and distributes oral spray nutritional and dietary products. Its distribution strategy includes selling to private label customers retailers, distributors, and consumers through retail outlets. Its wholly owned subsidiaries include Precision Analytic Testing, LLC, NutraDerma Technologies, Inc., PhytoChem Technologies, Inc., and TransDermalRX, Inc.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NUTRALIFE BIOSCIENCES, INC.	-50.00%	18.06K
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals